Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01708850
Recruitment Status : Completed
First Posted : October 17, 2012
Last Update Posted : September 8, 2016
Information provided by (Responsible Party):
Gwynivere Davies, London Health Sciences Centre